Effect of pluronic p85 on ATPase activity of drug efflux transporters

被引:138
作者
Batrakova, EV
Li, S
Li, YL
Alakhov, VY
Kabanov, AV
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA
[2] Supratek Pharma Inc, Dorval, PQ H9S 1A9, Canada
基金
英国惠康基金;
关键词
ATPase activity; Michaelis-Menten kinetics; MRP1; MRP2; Pgp; pluronic;
D O I
10.1007/s11095-004-7675-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Pluronic block copolymers are potent sensitizers of multidrug resistant (MDR) cancer cells. The sensitization effect by Pluronics is a result of two processes acting in concert: i) intracellular ATP depletion, and ii) inhibition of ATPase activity of drug efflux proteins. This work characterizes effects of Pluronic P85 on ATPase activities of Pgp, MRP1, and MRP2 drug efflux transport proteins and interaction of these proteins with their substrates, vinblastine, and leucotriene C-4. Methods.. Using membranes overexpressing Pgp, MRP1 and MRP2, the current study evaluates effects of Pluronic P85 (P85) on the kinetic parameters (V-max, K-m, V-max/K-m) of ATP hydrolysis by these ATPases. Results. The decreases in the maximal reaction rates (V-max)) and increases in apparent Michaelis constants (K) for these transporters in the presence of various concentrations of P85 were observed. The mechanism of these effects may involve i) conformational changes of the transporter due to membrane fluidization and/or ii) nonspecific steric hindrance of the drug-binding sites by P85 chains embedded into cellular membranes. The extent of these alterations was increased in the row MRP1 < MRP2 << Pgp. Conclusions. These data suggest that there are unifying pathways for the inhibition of Pgp and MRPs by the block copolymer. However, the effect of P85 on Pgp ATPase activity is considerably greater compared with the effects on MRP1 and MRP2 ATPases. This may be a reason for greater inhibitory effects of Pluronic in Pgp-compared with MRP-overexpressing cells.
引用
收藏
页码:2226 / 2233
页数:8
相关论文
共 47 条
  • [1] Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer
    Alakhov, VY
    Moskaleva, EY
    Batrakova, EV
    Kabanov, AV
    [J]. BIOCONJUGATE CHEMISTRY, 1996, 7 (02) : 209 - 216
  • [2] Biochemical, cellular, and pharmacological aspects of the multidrug transporter
    Ambudkar, SV
    Dey, S
    Hrycyna, CA
    Ramachandra, M
    Pastan, I
    Gottesman, MM
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 361 - 398
  • [3] Aszalos A, 1999, ANTICANCER RES, V19, P1053
  • [4] Batrakova EV, 2001, J PHARMACOL EXP THER, V299, P483
  • [5] Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells
    Batrakova, EV
    Li, S
    Alakhov, VY
    Miller, DW
    Kabanov, AV
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (02) : 845 - 854
  • [6] Sensitization of cells overexpressing multidrug-resistant proteins by Pluronic P85
    Batrakova, EV
    Li, S
    Alakhov, VY
    Elmquist, WF
    Miller, DW
    Kabanov, AV
    [J]. PHARMACEUTICAL RESEARCH, 2003, 20 (10) : 1581 - 1590
  • [7] Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion
    Batrakova, EV
    Li, S
    Elmquist, WF
    Miller, DW
    Alakhov, VY
    Kabanov, AV
    [J]. BRITISH JOURNAL OF CANCER, 2001, 85 (12) : 1987 - 1997
  • [8] The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins
    Bogman, K
    Erne-Brand, F
    Alsenz, J
    Drewe, J
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (06) : 1250 - 1261
  • [9] Chan HSL, 1997, CANCER RES, V57, P2325
  • [10] ATPase activity of purified multidrug resistance-associated protein
    Chang, XB
    Hou, YX
    Riordan, JR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) : 30962 - 30968